Elevated matrix metalloproteinase-2 and -3 production from human diabetic dermal fibroblasts

Summary Background Diabetic foot ulcers are characterized by elevated levels of matrix metalloproteinases (MMP), which could lead to excessive matrix breakdown and disruption to healing. It is unknown if this elevation is a function of wound healing, or if it is present within normal skin and a prim...

Full description

Saved in:
Bibliographic Details
Published inBritish journal of dermatology (1951) Vol. 149; no. 1; pp. 13 - 16
Main Authors Wall, S.J., Sampson, M.J., Levell, N., Murphy, G.
Format Journal Article
LanguageEnglish
Published Oxford, UK Blackwell Science Ltd 01.07.2003
Blackwell
Oxford University Press
Subjects
Online AccessGet full text
ISSN0007-0963
1365-2133
DOI10.1046/j.1365-2133.2003.05262.x

Cover

More Information
Summary:Summary Background Diabetic foot ulcers are characterized by elevated levels of matrix metalloproteinases (MMP), which could lead to excessive matrix breakdown and disruption to healing. It is unknown if this elevation is a function of wound healing, or if it is present within normal skin and a primary contributor to the increased risk of impaired healing. Objectives To determine whether diabetic fibroblasts from unwounded skin show elevated MMP production compared with their nondiabetic counterparts. Patients and methods Circular skin biopsies (4 mm diameter) were taken from the inside upper arm of four controls without diabetes and from four subjects with insulin‐treated diabetes. Fibroblasts were incubated for a further 72 h and conditioned medium was collected and stored at −20 °C. The conditioned medium was assessed by gelatin zymography and Western blotting for MMP‐2 and MMP‐3. Results Diabetic dermal fibroblasts showed significantly elevated production of MMP‐2 (P < 0·05) and pro‐MMP‐3 (P < 0·05) when compared with their nondiabetic counterparts. Conclusions Dermal fibroblasts from normal unwounded skin are characterized by increased MMP production and this may be a primary contributing factor to the increased risk of nonhealing foot ulceration in diabetes.
Bibliography:ArticleID:BJD5262
istex:1A4D318C9CA43AB8CC88F6E7CE547F523D5E40E5
ark:/67375/WNG-CV9CW921-M
SourceType-Scholarly Journals-1
ObjectType-General Information-1
content type line 14
ObjectType-Article-1
ObjectType-Feature-2
content type line 23
ISSN:0007-0963
1365-2133
DOI:10.1046/j.1365-2133.2003.05262.x